In line with these findings, expression of transdominant negative FOS, which interferes with all AP-1 isoforms, reduces CCND2 transcript levels and severely impairs proliferation of the RUNX1/RUNX1T1-expressing AML cells [9]. This evidence concerns the gene RUNX1T1 and acute myeloid leukemia.